available

Standards + Excelerate Copilots from Standards Core Now Available in the Microsoft Marketplace

HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Standards Core LLC today announced the availability of Standards + Excelerate Copilots in…

18 hours ago

MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025

Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase…

5 days ago

6G mobile networks will need up to three times today’s spectrum to meet surging data demands, new GSMA report shows.

Near-term government decisions to avoid future spectrum 'bottlenecks' are needed to benefit billions of consumers and businesses in a 6G…

6 days ago

Range Impact Reports 3Q 2025 Financial Results

Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public…

2 weeks ago

HarperCollins is proud to announce the publication of ‘The S.I.S. Story: How an accidental entrepreneur from Bihar created a global services conglomerate’ by Prince Mathews Thomas

Hardback | Non-Fiction/Memoir | 296 pp | INR 699 Available wherever books are sold | Released 13th October 2025 NEW DELHI, Nov. 13,…

2 weeks ago

Lamborghini Arena: the return of the most eagerly awaited event to experience the Lamborghini world

Tickets available from today for the event on 9 and 10 May at the Imola CircuitSant’Agata Bolognese, 12 November 2025…

2 weeks ago

Kia Unveils Disney, Marvel, Pixar, Star Wars and National Geographic Display Themes

Kia launches a series of new display themes featuring some of Disney’s most iconic brands, designed to delight fans of…

2 weeks ago

Virtune launches Virtune Stablecoin Index ETP on Nasdaq Stockholm, Nasdaq Helsinki and Deutsche Brse Xetra

November 05, 2025 03:49 ET  | Source: Virtune AB (Publ) Stockholm, November 5, 2025 – Virtune, a Swedish regulated crypto…

3 weeks ago

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…

4 weeks ago